The pharmaceutical and biotechnology sectors in both the United Arab Emirates (UAE) and Kingdom of KSA (KSA) are undergoing rapid transformation, driven by national visions, strategic investments, and global health trends.
The pharmaceutical and biotechnology sectors in both the United Arab Emirates (UAE) and Kingdom of KSA (KSA) are undergoing rapid transformation, driven by national visions, strategic investments, and global health trends. The pharmaceutical industry is a sector focused on the research, development, manufacturing, and commercialization of chemical-based drugs used to prevent, diagnose, and treat diseases. It includes prescription medicines, over-the-counter drugs, and vaccines. Pharmaceutical companies rely on chemistry, pharmacology, and clinical research to create safe and effective medications for human and animal health. The biotechnology industry involves the use of biological systems, living organisms, or their components—such as cells, genes, enzymes, or proteins—to develop innovative products and technologies. In healthcare, biotechnology companies create biologic therapies, including gene therapies, cell therapies, monoclonal antibodies, and other products made through genetic engineering and molecular biology. The industry aims to advance medical treatment, agriculture, and environmental sustainability.
